
PolyPeptide Group is a leading international GMP peptide manufacturer, operating six production sites worldwide. Our cutting-edge technology ensures the production of high-quality peptides with precision, efficiency, and full compliance with Good Manufacturing Practice (GMP) standards. We support pharmaceutical and biotech companies at every stage, from early development to commercial supply, helping bring innovative peptide-based therapeutics and diagnostics to market.
As the demand for peptide-based drugs continues to grow, agile and flexible manufacturing has become critical. PolyPeptide Group’s global production network enables us to rapidly adjust to shifting market needs, whether it be small-scale clinical trial batches or large-scale commercial supply.
Our flexible production approach allows for rapid scale-up, accommodating everything from early-stage development batches to full-scale commercial production. This ensures a seamless transition from research to market, reducing time-to-market for new peptide-based therapies. With a manufacturing infrastructure that can adapt quickly to production demands, we provide a stable and reliable supply chain that pharmaceutical and biotech companies can depend on.
By leveraging advanced synthesis platforms and automation, we optimise processes to improve efficiency and ensure cost-effective production. Our dedicated teams of experts continually enhance process development, optimising yield, purity, and consistency while maintaining full regulatory compliance.
PolyPeptide Group has been at the forefront of peptide manufacturing for decades, pioneering innovative synthesis techniques that allow us to produce highly complex peptides at a commercial scale.
Our expertise extends to:
- Long peptides: Optimised strategies for the synthesis of long and challenging sequences with high purity.
- Cyclic peptides: Specialised techniques for head-to-tail cyclisation and disulfide bond formation to enhance peptide stability and activity.
- Peptide conjugates: Conjugation of peptides with other molecules such as lipids, carbohydrates, or carrier proteins for improved therapeutic properties.
Our deep understanding of peptide chemistry allows us to overcome challenges associated with solubility, stability, and aggregation, ensuring high-yield, high-purity peptides suitable for pharmaceutical applications. We work closely with our partners to develop custom peptide solutions, tailoring manufacturing processes to meet specific formulation and regulatory requirements.
PolyPeptide Group is fully committed to meeting the highest GMP and regulatory standards, ensuring that our peptides are manufactured under strict quality control protocols. Each of our six global production sites adheres to internationally recognised Good Manufacturing Practice (GMP) guidelines, ensuring batch-to-batch consistency, purity, and safety.
Our regulatory expertise spans multiple regions, including the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other global regulatory bodies. We provide comprehensive documentation and regulatory support, simplifying the approval process for our customers and ensuring compliance with industry standards.
From early-phase clinical trials to commercial-scale production, we offer full traceability and rigorous quality assurance throughout the manufacturing process. Our state-of-the-art analytical capabilities ensure that all peptides meet the most stringent pharmaceutical and biotech industry specifications.
Innovation in peptide manufacturing is critical to advancing drug development and commercialisation. At PolyPeptide Group, we continuously invest in cutting-edge peptide synthesis technologies, automation, and process optimisation to enhance efficiency, scalability, and cost-effectiveness.
Global Reach, local expertise we are an international peptide manufacturer, PolyPeptide Group operates across six production sites worldwide, ensuring global reach while maintaining localised expertise. This allows us to serve pharmaceutical and biotech companies across multiple markets, providing efficient logistics, regional regulatory compliance, and market-specific support.
Our global infrastructure enables us to streamline supply chain management, ensuring timely delivery and uninterrupted production. By maintaining manufacturing operations in multiple locations, we provide:
- Risk mitigation through diversified production capabilities.
- Geographic flexibility to meet local regulatory and market demands.
- A responsive and scalable production network to handle varying batch sizes.
Why partner with PolyPeptide Group?
PolyPeptide Group is a trusted partner in peptide drug development and manufacturing, offering a unique combination of experience, expertise, and cutting-edge technology. Our ability to provide custom peptide solutions, GMP-compliant production, and scalable, flexible manufacturing makes us a preferred choice for pharmaceutical and biotech companies worldwide.
By working with us, you gain access to:
- Decades of expertise in peptide synthesis and manufacturing.
- GMP-certified production facilities with global regulatory compliance.
- Agile manufacturing capabilities that adapt to market demands.
- Cutting-edge technology to optimise efficiency and scalability.
- A worldwide production network ensuring reliable supply and risk mitigation.
At PolyPeptide Group, we are committed to driving innovation in peptide manufacturing while providing the highest quality products and services. Whether you require small-scale development batches or large commercial production, our expertise, technology, and global reach ensure a seamless, efficient, and cost-effective manufacturing process.
GMP Peptide Manufacturing for Pharmaceuticals and Biotech
PolyPeptide Group is a global leader in GMP peptide manufacturing, providing high-quality peptides for pharmaceutical and biotech applications. With six production sites worldwide, we offer scalable, flexible manufacturing solutions that support drug development from early-stage research to commercial production.
Our expertise in complex peptide synthesis allows us to produce long peptides, cyclic peptides, and peptide conjugates with high purity and consistency. By leveraging cutting-edge technology, we ensure reliable and efficient peptide manufacturing, tailored to the stringent quality and regulatory standards of the pharmaceutical industry.
With decades of experience in Good Manufacturing Practice (GMP) peptide production, we provide a seamless transition from clinical development to market supply. Our agile and scalable production capabilities help pharmaceutical and biotech companies bring innovative peptide-based therapies and diagnostics to patients faster..
Agile and Scalable Peptide Manufacturing ‒ Flexible to Market Demand
PolyPeptide Group provides agile and scalable peptide manufacturing to meet the evolving needs of pharmaceutical and biotech companies. Our flexible production approach allows for rapid scale-up, supporting everything from small clinical batches to full-scale commercial supply.
With state-of-the-art technology and a global network of six GMP-certified production sites, we ensure a reliable, high-quality peptide supply. Our manufacturing capabilities include solid-phase peptide synthesis (SPPS), allowing us to produce a wide range of therapeutic peptides, vaccine peptides, and peptide APIs.
By integrating advanced process optimisation and regulatory expertise, we help accelerate peptide drug development while maintaining stringent quality and compliance standards. Whether you need custom peptide synthesis or large-scale production, PolyPeptide Group delivers high-purity peptides with efficiency and precision.
GMP Peptide Manufacturing Regulatory Compliance Experts
PolyPeptide Group ensures GMP-compliant peptide manufacturing, meeting the highest regulatory standards for pharmaceutical and biotech applications. Our six global production sites operate under strict GMP guidelines, ensuring batch-to-batch consistency, purity, and safety.
We provide full regulatory support, including documentation, validation, and quality assurance, to streamline drug development and approval processes. Our expertise covers compliance with FDA, EMA, and other global regulatory agencies, ensuring peptides meet the strictest industry requirements for clinical and commercial use.
By maintaining rigorous quality control at every stage, we deliver high-purity peptides that support the successful development of peptide-based therapeutics, vaccines, and diagnostics. Our commitment to compliance, safety, and precision makes PolyPeptide Group a trusted partner in peptide manufacturing worldwide.
Custom Peptide Synthesis ‒ No Matter How Complex
PolyPeptide Group specialises in custom peptide synthesis, providing high-purity peptides for pharmaceutical and biotech applications. Our expertise in complex peptide manufacturing allows us to produce long peptides, cyclic peptides, and peptide conjugates with precision and efficiency.
With GMP-certified production facilities and state-of-the-art technology, we ensure peptides meet strict quality and regulatory standards for clinical and commercial use. Our team works closely with partners to develop tailored peptide solutions, optimising synthesis, scale-up, and formulation to meet specific project needs.
Looking for a reliable peptide manufacturing partner? Contact us today to discuss your custom peptide synthesis requirements and learn how we can support your drug development process.